What this guide covers
The definition in one sentence
Regulatory intelligence software continuously collects, consolidates and cross-references what regulators and the open market are saying about your medical devices (adverse events, recalls, safety notices, enforcement actions and unauthorised listings), so your team works from one current view instead of a dozen government websites.
The focus is on external information. Your quality system records what happens inside your company: complaints received, CAPAs opened, audits passed. Regulatory intelligence covers what happens outside it: what the FDA, MHRA, Health Canada and other regulators have published about your devices (and your competitors'), and where your products are turning up on the open market.
Why the category exists
Three things created it:
- Scattered sources. A manufacturer selling into the US, UK, EU, Canada and Switzerland has to follow many regulatory publishers, among them openFDA, the MHRA, Health Canada, Swissmedic and the EU's EUDAMED database. Each has its own site, format, search and update schedule, and none republishes the others. (Our guide to monitoring beyond the FDA details what each one publishes.)
- Rising obligations. EU MDR made post-market surveillance a written, ongoing duty rather than something done in the background, with reports and evidence that a Notified Body reviews. The FDA's quality system requirements (21 CFR 820) point the same way on complaints and risk management.
- The resale market moved online. Devices now turn up on Amazon, eBay, Walmart, Google Shopping and medical resale sites like DotMed and LabX: diverted stock, decommissioned hospital equipment, and occasionally recalled or investigational units. No regulator watches that for you.
Monitoring all three by hand is hard to keep up. Teams either narrow their scope (usually to the FDA only), check less often (quarterly sweeps), or both. Each of those leaves a gap that can cost you in an audit.
The four jobs it does
1. Consolidated lookup
Search a device once and see safety and enforcement notices, adverse events and registrations from every covered regulator, side by side. That replaces six browser tabs and a spreadsheet. Because the data is collected in advance rather than fetched live, lookups are fast and give the same answer each time.
2. Continuous monitoring
Watchlists on your device portfolio, checked on a schedule rather than when someone remembers. New signals arrive as notifications (in the app, by email or by webhook into your other systems) instead of waiting to be found.
3. Open-market surveillance
The same watchlists, applied to resale marketplaces. This means finding your devices listed by sellers you don't recognise, checking that a listing really is your device (newer tools use AI image analysis for this), and supporting the takedown process. Our guide to the grey market for medical devices covers why this matters more than most teams expect.
4. Evidence and reporting
Everything found is logged and timestamped, and listing pages are captured as a screenshot and page copy where the marketplace allows it. The monitoring that alerts you also builds the record your PMS report or PSUR needs. When an auditor asks "how did you know, and when?", you can show a log instead of relying on memory.
How it differs from a QMS or eQMS
The two work together. It helps to be clear about where one ends and the other begins:
| QMS / eQMS | Regulatory intelligence | |
|---|---|---|
| Primary data | Internal: complaints, CAPAs, documents, training, audits | External: regulator publications, adverse-event databases, marketplace listings |
| Direction | Records what your company does | Watches what the world says and does |
| Trigger | Events reported to you | Signals you'd otherwise never receive |
| Typical owner | Quality | Regulatory affairs, quality, brand protection |
A regulatory intelligence platform doesn't replace your complaint handling, document control or CAPA process. It feeds them: an adverse-event cluster or a grey-market finding becomes an input to the processes your QMS already runs.
Who uses it
- Regulatory affairs: device lookups across jurisdictions, PMS data collection, report preparation.
- Quality: signal detection feeding trend analysis and CAPA, evidence for audits.
- Brand protection and legal: unauthorised listing detection, seller patterns, evidence capture for takedowns and disputes.
At smaller manufacturers these are often the same two or three people, so having everything in one place matters even more.
What it looks like day to day
Here is how it works in MedFortis. It's our own platform, so take this section as a description of where we sit in the category. A regulatory affairs specialist types a device name once and gets results from openFDA, the MHRA, Health Canada, Swissmedic, EUDAMED and other national sources: adverse events, safety notices and recalls in one view, with report annexes for PMS and PSUR submissions on demand.
The same device also sits on a watchlist that is scanned on a schedule across the marketplaces configured for your deployment (Google Shopping by default, eBay where configured, and other connectors such as DotMed and LabX enabled per deployment). Candidate listings are checked by AI image analysis and given a confidence score, and coordinated sellers are linked together. Each listing flagged for review is captured as a full-page screenshot and page copy where the marketplace allows it, each hashed and logged. Alerts arrive in a notification centre, by email or by webhook. Access runs through SSO with MFA, and each customer has its own isolated environment, which covers what most enterprise security reviews ask about.
Where post-market surveillance fits
Post-market surveillance is the obligation. Regulatory intelligence is what supplies the information for it. Under EU MDR Articles 83–92, every manufacturer must run a documented PMS system that actively collects the kind of external data described here, and produce a PMS report or PSUR from it. That's why PMS is usually the first reason companies buy a regulatory intelligence platform, even though the same data also helps with competitor research and brand protection.
See regulatory intelligence on your own devices
The quickest way to understand the category is to see it run on your own portfolio. A free MedFortis demo does that: one lookup across regulator sources plus the resale market, live, on your device lines.
Book a Demo →Key takeaways
- Regulatory intelligence software brings external information (regulator publications and open-market activity) into one up-to-date view of your devices.
- It exists because sources are scattered (many regulators, none republishing the others), PMS obligations have grown, and the resale market has moved online.
- Its four jobs: consolidated lookup, continuous monitoring, open-market surveillance, and evidence and reporting.
- It works alongside a QMS rather than replacing it. External information comes in and feeds the internal processes you already run.
- The category test: when a regulator publishes about your device, how long until you know?